Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure
- PMID: 3734263
- DOI: 10.1016/s0735-1097(86)80060-2
Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure
Abstract
Newer positive inotropic agents used in the treatment of severe heart failure not only increase cardiac contractility, but also cause peripheral vasodilation. It is not known to what extent this vasodilation is due to a direct peripheral action of the drug, as opposed to reflex withdrawal of sympathetic tone secondary to an augmented inotropic state. In 16 patients with severe heart failure, a 48 hour intravenous infusion of milrinone, a positive inotropic vasodilator drug, resulted in an increase in stroke volume index from 26 +/- 2 to 34 +/- 3 ml/m2 (p less than 0.001), a reduction in forearm vascular resistance measured by venous plethysmography from 43 +/- 5 to 27 +/- 3 U (p less than 0.003) and an increase in forearm venous capacitance from 2.1 +/- 0.2 to 2.9 +/- 0.2 ml/100 ml (p less than 0.001). To determine whether a withdrawal of sympathetic tone contributed to this vasodilation, milrinone was infused directly into the left main coronary artery in eight of the patients, thereby eliminating any direct vascular effects of the drug. Intracoronary milrinone (50 micrograms/min) caused an increase in peak positive first derivative of pressure (658 +/- 49 to 784 +/- 68 mm Hg/s; p less than 0.01) and stroke volume index (20 +/- 2 to 25 +/- 3 ml/m2; p less than 0.0001), which was associated with a reduction in plasma norepinephrine from 540 +/- 101 to 423 +/- 90 pg/ml (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.Circulation. 1986 Mar;73(3 Pt 2):III175-83. Circulation. 1986. PMID: 3510774 Clinical Trial.
-
Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.Circulation. 1986 Jan;73(1):130-7. doi: 10.1161/01.cir.73.1.130. Circulation. 1986. PMID: 3940664
-
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.Am J Cardiol. 1989 Jan 3;63(2):17A-22A. doi: 10.1016/0002-9149(89)90387-1. Am J Cardiol. 1989. PMID: 2909993
-
Myocardial and vascular actions of milrinone.Eur Heart J. 1989 Aug;10 Suppl C:32-8. doi: 10.1093/eurheartj/10.suppl_c.32. Eur Heart J. 1989. PMID: 2680495 Review.
-
Acute effects of intravenous milrinone in heart failure.Eur Heart J. 1989 Aug;10 Suppl C:39-43. doi: 10.1093/eurheartj/10.suppl_c.39. Eur Heart J. 1989. PMID: 2680496 Review.
Cited by
-
Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.Clin Pharmacokinet. 2014 Jan;53(1):51-72. doi: 10.1007/s40262-013-0096-z. Clin Pharmacokinet. 2014. PMID: 23839530
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical